PHARMACY

Amneal Pharmaceuticals announced on Tuesday the launch of Phytonadione Tablets, USP, 5 mg, the first AB-rated therapeutic equivalent for Mephyton.

The Food and Drug Administration on Tuesday approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia.

In a move that’s considered an “important step forward for patients coping with skyrocketing health care costs,” Association for Accessible Medicines president and CEO Chester “Chip” Davis, Jr., praised President Trump for making clear in his remarks on Friday the important role that generic and biosimilar medicines play in containing prescription drug costs for patients.

Specialty pharmaceutical company Aquestive Therapeutics has reached a settlement agreement resolving patent litigation related to Suboxone (buprenorphine and naloxone) Sublingual Film.

Weis Markets’ dietitian in the Lewisburg, Pa., area began working with local healthcare providers on diabetic workshops in the past year.

In an effort to battle the opioid epidemic, Iowa is tackling the issue of doctor shopping and over-prescribing in the state with a bipartisan piece of legislation signed Monday by Gov. Kim Reynolds.

Adello Biologics, a U.S.-based biotechnology company headquartered in Piscataway, N.J., has named Amneal co-chairman Chintu Patel as CEO, effective immediately. Patel succeeds Peter Moesta, who is stepping down to pursue other opportunities.

Creating Rite Aid pharmacies within Albertsons banners will help the pair fold into more narrow networks, executives said.